Skip to main content
SpringerLink
Log in

Treatment of Diabetes Insipidus in Adults

  • Chapter
Hormone Replacement Therapy

Part of the book series: Contemporary Endocrinology ((COE,volume 13))

Abstract

Diabetes insipidus (DI) is a syndrome characterized by the excretion of abnormally large volumes of dilute urine. The polyuria causes symptoms of urinary frequency and nocturia and sometimes, incontinence and enuresis. It is also associated with thirst and/or a commensurate increase in fluid intake (polydipsia).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am 1995; 24: 549–572.

    PubMed  CAS  Google Scholar 

  2. Hansen LK, Rittig S, Robertson GL. Genetic basis of familial neurohypophyseal diabetes insipidus. TEM 1997; 8: 363–372.

    PubMed  CAS  Google Scholar 

  3. Durr JA. Diabetes insipidus in pregnancy. Am J Kidney Dis 1987; 9: 276–283.

    PubMed  CAS  Google Scholar 

  4. Knoers N, Monnens LAH. Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment (invited review). Pediatr Nephrol 1992; 6: 476–482.

    Article  PubMed  CAS  Google Scholar 

  5. Robertson GL. Dipsogenic Diabetes insipidus: a newly recognized syndrome caused by a selective defect in the osmoregulation of thirst. Trans Assoc Physician 1987; 100: 241–249.

    CAS  Google Scholar 

  6. Illowsky BP, Kirch DG. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry 1988; 145: 675–683.

    PubMed  CAS  Google Scholar 

  7. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med 1988; 318: 397–403.

    Article  PubMed  CAS  Google Scholar 

  8. Zimmerman EA, Ma LY, Nilaver G. Anatomical basis of thirst and vasopressin secretion. Kidney Int 1987; 32 (suppl 21): S14 - S19.

    Google Scholar 

  9. Schmale H, Fehr S, Richter D. Vasopressin biosynthesis-from gene to peptide hormone. Kidney Int 1987; 32 (suppl 21): S8 - S13.

    Google Scholar 

  10. Knepper MA, Wade JB, Terris J, et al. Renal aquaporins. Kidney Int 1996; 49: 1712–1717.

    Article  PubMed  CAS  Google Scholar 

  11. Nielsen S, Marples D, Frokiaer J, et al. The aquaporin family of water channels in kidney: an update on physiology and pathophysiology of aquaporin-2. Kidney Int 1996; 49: 1718–1723.

    Article  PubMed  CAS  Google Scholar 

  12. Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449–1455.

    PubMed  CAS  Google Scholar 

  13. Zerbe RL, Robertson GL. Osmotic and nonosmotic regulation of thirst and vasopressin secretion. In: Narins RG, ed. Clinical disorders of fluid and electrolyte metabolism. McGraw Hill, New York, NY, 1994, pp. 81–100.

    Google Scholar 

  14. Robertson GL. Differential diagnosis of polyuria. Ann Rev Med 1988; 39: 425–442.

    Article  PubMed  CAS  Google Scholar 

  15. Elster AD. Modern imaging of the pituitary. Radiology 1993; 187: 1–14.

    PubMed  CAS  Google Scholar 

  16. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med 1985; 103: 228–239.

    PubMed  CAS  Google Scholar 

  17. Fjellstad-Paulsen A, Paulsen O, d’Agay-Abensour L, Lundin S, Czernichow P. Central diabetes insipidus:oral treatment with dDAVP. Reg Pep 1993; 45: 303–307.

    Article  Google Scholar 

  18. Lam KS, Wat MS, Choi KL, Ip TP, Pang RWC, Kumana CR. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginie vasopressin in adult patients with central diabetes insipidus. Br J Clin Pharm 1996; 42: 379–385.

    Article  CAS  Google Scholar 

  19. Robertson GL. Posterior pituitary. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and Metabolism, 3rd ed. McGraw Hill, New York, 1995, pp. 385–432.

    Google Scholar 

  20. Byun KY, Gaskill MB, Robertson GL. The mechanism of chlorpropamide antidiuresis in diabetes insipidus. Clin Res 1984;32:483 A.

    Google Scholar 

  21. Moses AM, Numann P, Miller M. Mechanism of chlorpropamide-induced antidiuresis in man: evidence for release of ADH and enchancement of peripheral action. Metabolism 1973; 22: 59–66.

    Article  PubMed  CAS  Google Scholar 

  22. Moses AM, Howanitz J, van Gemert M, Miller M. Clofibrate-induced antidiuresis. J Clin Invest (1973) 52: 535–542.

    Article  PubMed  CAS  Google Scholar 

  23. Thompson P Jr, Earll JM, Schaaf M. Comparison of clofibrate and chlorpropamide in vasopressinresponsive diabetes insipidus. Metabolism 1977; 26: 749–762.

    Article  PubMed  CAS  Google Scholar 

  24. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxacarbazepine therapy: a review. Epilepsia 1994; 35: 181–188.

    Article  PubMed  Google Scholar 

  25. Stephens WP, Coe JY, Baylis PH. Plasma arginine vasopressin concentration and antidiuretic action of carbamazepine. Br Med J 1978; 1: 1445–1447.

    Article  PubMed  CAS  Google Scholar 

  26. Gold PW, Robertson GL, Ballenger JC, et al. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab 1983; 57: 952–957.

    Article  PubMed  CAS  Google Scholar 

  27. Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide-induced hyponatremia: Reproducibility by single dose rechalenge and an analysis of pathogenesis. Ann Intern Med 1989; 110: 24–30.

    PubMed  CAS  Google Scholar 

  28. Walter SJ, Skinner J, Laycock JF, et al. The antidiuretic effect of chronic hydrochlorothiazide treatment in rats with diabetes insipidus: Water and electrolyte balance. Clin Sci 1982; 63: 525–532.

    PubMed  CAS  Google Scholar 

  29. Shirley DG, Walter SJ, Laycock JF. The antidiuretic effect of chronic hydrochlorothiazide treatment in rats with diabetes insipidus: renal mechanisms. Clin Sci 1982; 63: 533–538.

    PubMed  CAS  Google Scholar 

  30. Seckl JR, Dunger DB. Postoperative DI. Br Med J 1989; 298: 2–3.

    Article  CAS  Google Scholar 

  31. Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature and personal experience. Neurosurgery 1997; 40: 225–236.

    Article  PubMed  CAS  Google Scholar 

  32. Seckl JR, Dunger DB. Neurohypophyseal peptide function during early postoperative diabetes insipidus. Brain 1987; 110: 737–746.

    Article  PubMed  Google Scholar 

  33. Lindsay RS, Seckl JR, Padfield PL. The triple phase response-problems of water balance after pituitary surgery. Postgrad Med J 1995; 71: 439–441.

    Article  PubMed  CAS  Google Scholar 

  34. Robertson GL. Disorders of thirst in man. In: Ramsay DJ, Booth DA, eds. Thirst: Physiological and Psychological Aspects. Springer-Verlag, New York, 1991, pp. 453–475.

    Google Scholar 

  35. Phillips PA, Phil D, Rolls BJ, Ledingahm JGG, Forsling ML, Morton JJ, Crowe MJ, Wollner L. Reduced thirst after water deprivation in healthy elderly men. NEJM 1984; 311: 753–759.

    Article  PubMed  CAS  Google Scholar 

  36. Robertson GL. Abnormalities of thirst regulation. Kidney Internat 1984; 25: 460–469.

    Article  CAS  Google Scholar 

  37. Perez GO, Ostre JR, Robertson GL. Severe hypernatremia with impaired thirst. Am J Nephrol 1989; 9: 421–434.

    Article  PubMed  CAS  Google Scholar 

  38. Nandi M, Harrington AR. Succesful treatment of hypernatremic thirst deficiency with chlorpropamide. Clin Nephrol 1978; 10: 90–95.

    PubMed  CAS  Google Scholar 

  39. Vokes TJ, Gaskill MB, Robertson GL. Antibodies to vasopressin in patients with diabetes insipidus. Ann Inter Med 1988; 108: 190–195.

    CAS  Google Scholar 

  40. Iwasacki Y, Oiso Y, Kondo K, et al. Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med 1991; 324: 522–526.

    Article  Google Scholar 

  41. Durr JA, Hoggard JG, Hunt JM, Schrier RW. Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity. N Engl J Med 1987; 316: 1070–1074.

    Article  PubMed  CAS  Google Scholar 

  42. Lindheimer MD, Davison JM. Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. Eur J Endocrinol 1995; 132: 133–143.

    Article  PubMed  CAS  Google Scholar 

  43. Kallen BAJ, Carlsson SS, Bengtsson BKA. Diabetes insipidus and use of desmopressin (Minirin®) during pregnancy. Eur J Endocrinol 1995; 132: 144–146.

    Article  PubMed  CAS  Google Scholar 

  44. Kinsley BT, Swift M, Dumont RH, Swift RG. Morbidity and mortality in the Wolfram syndrome. Diabetes Care 1995; 18: 1566–1570.

    Article  PubMed  CAS  Google Scholar 

  45. Barett TG, Bundey SE. Wolfram (DIDMOAD) syndrome. J Med Genet 1997;34:838–841.

    Google Scholar 

  46. Karasik A, O’Hara C, Sriknata S, et al. Genetically Programmed Selective Islet 13-cell loss in diabetic subjects with Wolfram’s syndrome. Diabetes Care 1989; 12: 135–138.

    Article  PubMed  CAS  Google Scholar 

  47. Thompson CJ, Charlton SW, Walford S, et al. Vasopresson secretion in the DIDMOAD (Wolfram) syndrome. QJM 1989; 71: 333–345.

    PubMed  CAS  Google Scholar 

  48. Alon U, Chan JCM. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol 1985; 5: 9–13.

    Article  PubMed  CAS  Google Scholar 

  49. Battle DC, von Riotte AB, Gaviria M, Grupp M. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408–414.

    Article  Google Scholar 

  50. Libber S, Harrison H, Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 1986; 108: 305–311.

    Article  PubMed  CAS  Google Scholar 

  51. Jakobsson B, Berg U. Effect of hydrochlorothiazide and indomethacin treatment on ranal function in nephrogenic diabetes insipidus. Acta Pediatr 1994; 83: 522–525.

    Article  CAS  Google Scholar 

  52. Monn E. Prostaglandin synthetase inhibitors in the treatment of nephrogenic diabetes insipidus. Acta Pediatr Scand 1981; 70: 39–42.

    Article  CAS  Google Scholar 

  53. Allen HM, Jackson RL, Winchester MD, Deck LV, Allon M. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med 1989; 149: 1123–1126.

    Article  PubMed  CAS  Google Scholar 

  54. Monnens L, Jonkman A, Thomas C. Response to indomethacin and hydrochlorothiazide in nephrogenic diabetes insipidus. Clin Sci 1984; 66: 709–715.

    PubMed  CAS  Google Scholar 

  55. Boton R, Gaviria M, Battle DC. Prevalence, pathogenesis and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987; 1O (5): 329–345.

    Google Scholar 

  56. Himmelhoch JM, Forrest J, Neil JF, Detre TP. Thiazide-lithium synergy in refractory mood swings. Am J Psychiatry 1977; 134: 149–152.

    PubMed  CAS  Google Scholar 

  57. Hariprasad MK, Eisinger RP, et al. Hyponatremia in psychogenic polydipsia. Arch Intern Med 1980; 140: 1639–1642.

    Article  PubMed  CAS  Google Scholar 

  58. Siegler El, Tamres D, Berlin JA, et al. Risk factors for the development of hyponatremia in psychiatric inpatients. Arch Intern Med 1995; 155: 953–957.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Andjela T. Drincic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary L. Robertson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Endocrinology and Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA

    A. Wayne Meikle MD

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Drincic, A.T., Robertson, G.L. (1999). Treatment of Diabetes Insipidus in Adults. In: Meikle, A.W. (eds) Hormone Replacement Therapy. Contemporary Endocrinology, vol 13. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-700-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-700-0_2

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-092-2

  • Online ISBN: 978-1-59259-700-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation